Literature DB >> 28528146

Prognostic Value of Coronary CT Angiography With Selective PET Perfusion Imaging in Coronary Artery Disease.

Teemu Maaniitty1, Iida Stenström1, Jeroen J Bax2, Valtteri Uusitalo1, Heikki Ukkonen3, Sami Kajander1, Maija Mäki4, Antti Saraste5, Juhani Knuuti6.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the prognostic value of sequential hybrid imaging strategy in which positron emission tomography (PET) perfusion imaging is performed selectively in patients with suspected obstructive coronary artery disease (CAD) on coronary computed tomography angiography (CTA).
BACKGROUND: Coronary CTA is an accurate diagnostic test for excluding obstructive CAD. However, the positive predictive value is suboptimal.
METHODS: We investigated 864 consecutive symptomatic patients with intermediate probability of CAD who adhered to the sequential imaging approach. PET myocardial perfusion imaging using 15O-labeled water during adenosine stress was performed when suspected obstructive stenosis was present on coronary CTA. The major adverse events (AEs) including all-cause mortality, myocardial infarction (MI), and unstable angina pectoris (UAP) were recorded.
RESULTS: During a median follow-up of 3.6 years, 16 deaths, 10 MIs, and 5 UAPs occurred. Obstructive CAD was excluded by coronary CTA in 462 (53%) patients who had significantly lower annual AE rate than did patients with suspected obstructive stenosis on coronary CTA (0.4% vs. 1.5%; p = 0.003). The latter underwent PET study, on which 195 (49%) had normal and 207 had abnormal perfusion. The annual rate of AEs was 5 times higher in those with abnormal perfusion than with normal perfusion (2.5% vs. 0.5%; p = 0.004). Patients with normal perfusion had AE rate comparable to patients without obstructive CAD on coronary CTA (p = 0.77).
CONCLUSIONS: In patients with suspected CAD obstructive disease can be excluded in 53% of patients by coronary CTA, and these patients have good outcome. About one-half (49%) of the remaining patients have normal perfusion and event rate comparable to patients without obstructive CAD on coronary CTA while patients with ischemia have clearly worse outcome. Sequential approach utilizing anatomical imaging by coronary CTA followed by selective functional perfusion imaging is a feasible strategy to diagnose and risk-stratify patients with suspected CAD.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  computed tomography angiography; coronary artery disease; hybrid imaging; myocardial perfusion; positron emission tomography

Mesh:

Substances:

Year:  2017        PMID: 28528146     DOI: 10.1016/j.jcmg.2016.10.025

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  8 in total

1.  SPECT but not PET remains as the working horse of the state of the art nuclear cardiac imaging laboratory: Con.

Authors:  Antti Saraste; Juhani Knuuti
Journal:  J Nucl Cardiol       Date:  2017-07-31       Impact factor: 5.952

Review 2.  PET-Based Imaging of Ischemic Heart Disease.

Authors:  Kevin Chen; Edward J Miller; Mehran M Sadeghi
Journal:  PET Clin       Date:  2019-02-01

3.  Coronary computed tomography angiography-based endothelial wall shear stress in normal coronary arteries.

Authors:  Jussi Schultz; Inge J van den Hoogen; Jurrien H Kuneman; Michiel A de Graaf; Vasileios Kamperidis; Alexander Broersen; J Wouter Jukema; Antonis Sakellarios; Sotirios Nikopoulos; Konstantina Tsarapatsani; Katerina Naka; Lampros Michalis; Dimitrios I Fotiadis; Teemu Maaniitty; Antti Saraste; Jeroen J Bax; Juhani Knuuti
Journal:  Int J Cardiovasc Imaging       Date:  2022-10-18       Impact factor: 2.316

4.  Quantitative myocardial perfusion evaluation with positron emission tomography and the risk of cardiovascular events in patients with coronary artery disease: a systematic review of prognostic studies.

Authors:  Luis Eduardo Juárez-Orozco; Rene A Tio; Erick Alexanderson; Marc Dweck; Rozemarijn Vliegenthart; Mostafa El Moumni; Niek Prakken; Ivan Gonzalez-Godinez; Riemer H J A Slart
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-10-01       Impact factor: 6.875

5.  EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging.

Authors:  Roberto Sciagrà; Mark Lubberink; Fabien Hyafil; Antti Saraste; Riemer H J A Slart; Denis Agostini; Carmela Nappi; Panagiotis Georgoulias; Jan Bucerius; Christoph Rischpler; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-02       Impact factor: 9.236

6.  Incremental prognostic value of hybrid [15O]H2O positron emission tomography-computed tomography: combining myocardial blood flow, coronary stenosis severity, and high-risk plaque morphology.

Authors:  Roel S Driessen; Michiel J Bom; Pepijn A van Diemen; Stefan P Schumacher; Remi M Leonora; Henk Everaars; Albert C van Rossum; Pieter G Raijmakers; Peter M van de Ven; Cornelis C van Kuijk; Adriaan A Lammertsma; Juhani Knuuti; Amir Ahmadi; James K Min; Jonathon A Leipsic; Jagat Narula; Ibrahim Danad; Paul Knaapen
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-10-01       Impact factor: 6.875

7.  Global and segmental absolute stress myocardial blood flow in prediction of cardiac events: [15O] water positron emission tomography study.

Authors:  Esa Harjulahti; Teemu Maaniitty; Wail Nammas; Iida Stenström; Fausto Biancari; Jeroen J Bax; Juhani Knuuti; Antti Saraste
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-11       Impact factor: 9.236

8.  Assessment of a digital and an analog PET/CT system for accurate myocardial perfusion imaging with a flow phantom.

Authors:  Reetta Siekkinen; Anna K Kirjavainen; Kalle Koskensalo; Nadia A S Smith; Andrew Fenwick; Virva Saunavaara; Tuula Tolvanen; Hidehiro Iida; Antti Saraste; Mika Teräs; Jarmo Teuho
Journal:  J Nucl Cardiol       Date:  2021-05-04       Impact factor: 3.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.